Experimental models of schizophrenia - A review;Modelos experimentais de esquizofrenia - Uma revisão

Revista Brasileira de Psiquiatria

Volumn 28, Issue 2, 2006, Pages 135-141

  Salgado, João Vinícius ^a,d   Hetem, Luiz Alberto ^b   Sandner, Guy ^c  

^a FUNDAÇÃO HOSPITALAR DO ESTADO DE MINAS GERAIS   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

^c UNIVERSITÉ DE STRASBOURG   (France)

^d NONE   (Brazil)

Author keywords

Evaluation studies; Experimental models; Feasibility studies; Review literature; Schizophrenia

Indexed keywords

DISEASE SEVERITY; ENVIRONMENTAL FACTOR; EYE MOVEMENT; HABITUATION; HEREDITY; HUMAN; LOCOMOTION; MEDICAL RESEARCH; NONHUMAN; PHENOTYPE; REVIEW; SCHIZOPHRENIA; SOCIAL INTERACTION; SYMPTOMATOLOGY;

ANIMALS; DISEASE MODELS, ANIMAL; FEASIBILITY STUDIES; HUMANS; PHENOTYPE; RATS; REPRODUCIBILITY OF RESULTS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 33746159890     PISSN: 15164446     EISSN: 15164446     Source Type: Journal    
DOI: 10.1590/S1516-44462006000200012     Document Type: Review

References (60)

1. Geyer MA, Moghaddam B. Animals models relevant to schizophrenia disorders. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology, The Fifth Generation of Progress. Baltimore, MD: Lippincott, Williams e Wilkins; 2002; Chapter 50. p. 689-701.
2. McKinney WT Jr, Bunney WE Jr. Animal model of depression. I. Review of evidence: implications for research. Arch Gen Psychiatry. 1969;21(2):240-8. Review.
3. Ellenbroek BA, Cools AR. Animal models with construct validity for schizophrenia. Behav Pharmacol. 1990;1(6):469-90.
4. Willner P. The validity of animal models of depression. Psychopharmacology (Berl). 1984;83(1):1-16. Review.
5. Kilts CD. The changing roles and targets for animal models of schizophrenia. Biol Psychiatry. 2001;50(11):845-55. Erratum in: Biol Psychiatry. 2002;51(4):346.
6. Seong E, Seasholtz AF, Burmeister M. Mouse models for psychiatric disorders. Trends Genet. 2002;18(12):643-50. Review.
7. Braff DL, Geyer MA, Swerdlow NR. Human studies of prepulse inhibition of startle: normal subjects, patient groups, and pharmacological studies. Psychopharmacology (Berl). 2001;156(2-3):234-58. Review.
8. Elden A, Flaten MA. Similar effects of attention directed to acoustic and tactile stimuli on prepulse inhibition of acoustic startle. Scand J Psychol. 2003;44(4):363-72.
9. Freedman R, Adler LE, Gerhardt GA, Waldo M, Baker N, Rose GM, Drebing C, Nagamoto H, Bickford-Wimer P, Franks R. Neurobiological studies of sensory gating in schizophrenia. Schizophr Bull. 1987;13(4):669-78.
10. Braff DL, Freedman R. Endophenotypes in studies of the genetics of schizophrenia. In: Davis KL, Charney D, Coyle JT, Nemeroff C, eds. Neuropsychopharmacology, The Fifth Generation of Progress. Baltimore, MD: Lippincott, Williams e Wilkins; 2002. Chapter 51, p. 703-16.
11. McCarley RW, Shenton ME, O'Donnell BF, Faux SF, Kikinis R, Nestor PG, Jolesz FA. Auditory P300 abnormalities and left posterior superior temporal gyrus volume reduction in schizophrenia. Arch Gen Psychiatry. 1993;50(3):190-7.
12. Grillon C, Ameli R, Glazer WM. N400 and semantic categorization in schizophrenia. Biol Psychiatry. 1991;29(5):467-80.
13. Lubow RE, Gewirtz JC. Latent inhibition in humans: data, theory and implications for schizophrenia. Psychol Bull. 1995;117(1):87-103. Review.
14. Goldberg TE, Torrey EF, Gold JM, Ragland JD, Bigelow LB, Weinberger DR. Learning and memory in monozygotic twins discordant for schizophrenia. Psychol Med. 1993;23(1):71-85. Review.
15. Keri S, Janka Z. Critical evaluation of cognitive dysfunctions as endophenotypes of schizophrenia. Acta Psychiatr Scand. 2004;110(2):83-91.
16. Siever LJ, Haier RJ, Coursey RD, Sostek AJ, Murphy DL, Holzman PS, Buchsbaum MS. Smooth pursuit eye tracking impairment: relation to other 'markers' of schizophrenia and psychologic correlates. Arch Gen Psychiatry. 1982;39(9):1001-5.
17. Delevoye-Turrell Y, Giersch A, Danion JM. Abnormal sequencing of motor actions in patients with schizophrenia: evidence from grip force adjustments during object manipulation. Am J Psychiatry. 2003;160(1):134-41.
18. Posner MI, Early TS, Reiman E, Pardo PJ, Dhawan M. Asymmetries in hemispheric control of attention in schizophrenia. Arch Gen Psychiatry. 1988;45(9):814-21.
19. Siever LJ, Davis KL. The pathophysiology of schizophrenia disorders: perspectives from the spectrum. Am J Psychiatry. 2004;161(3):398-413. Review.
20. Castner SA, Goldman-Rakic PS, Williams GV. Animal models of working memory: insights for targeting cognitive dysfunction in schizophrenia. Psychopharmacology (Berl). 2004;174(1):111-25.
21. Robbins TW. Chemical neuromodulation of frontal-executive functions in humans and other animals. Exp Brain Res. 2000;133(1):130-8. Review.
22. Cadenhead KS, Light GA, Geyer MA, Braff DL. Sensory gating deficits assessed by the P50 event-related potential in subjects with schizotypal personality disorder. Am J Psychiatry. 2000;157(1):55-9.
23. Siever LJ, Friedman L, Moskowitz J, Mitropoulou V, Keefe R, Roitman SL, Merhige D, Trestman R, Silverman J, Mohs R. Eye movement impairment and schizotypal psychopathology. Am J Psychiatry. 1994;151(8):1209-15.
24. Angrist BM, Shopsin B, Gershon S. Comparative psychotomimetic effects of stereoisomers of amphetamine. Nature. 1971;234(5325):152-3.
25. Luby ED, Gottlieb JS, Cohen BD, Rosenbaum G, Domino EF. Model psychoses and schizophrenia. Am J Psychiatry. 1962;119:61-7.
26. Hetem LA, Danion JM, Diemunsch P, Brandt C. Effect of a subanesthetic dose of ketamine on memory and conscious awareness in healthy volunteers. Psychopharmacology (Berl). 2000;152(3):283-8.
27. Swerdlow NR, Geyer MA. Using an animal model of deficient sensorimotor gating to study the pathophysiology and new treatments of schizophrenia. Schizophr Bull. 1998;24(2):285-301. Review.
28. Ralph RJ, Varty GB, Kelly MA, Wang YM, Caron MG, Rubinstein M, Grandy DK, Low MJ, Geyer MA. The dopamine D2, but not D3 or D4, receptor subtype is essential for the disruption of prepulse inhibition produced by amphetamine in mice. J Neurosci. 1999;19(11):4627-33.
29. Canal NM, Gourevitch R, Sandner G. Non-monotonic dependency of PPI on temporal parameters: differential alteration by ketamine and MK-801 as opposed to apomorphine and DOI. Psychopharmacology (Berl). 2001;156(2-3):169-76.
30. Geyer MA. Behavioral studies of hallucinogenic drugs in animals: implications for schizophrenia research. Pharmacopsychiatry. 1998;31(Suppl2):73-9. Review.
31. Swerdlow NR, Braff DL, Masten VL, Geyer MA. Schizophrenic-like sensorimotor gating abnormalities in rats following dopamine infusion into the nucleus accumbens. Psychopharmacology (Berl). 1990;101(3):414-20.
32. Ellenbroek BA, Budde S, Cools AR. Prepulse inhibition and latent inhibition: the role of dopamine in the medial prefrontal cortex. Neuroscience. 1996;75(2):535-42.
33. Salgado JV, Vidal M, Oberling P, Graeff FG, Danion JM, Sandner G. Associative learning and latent inhibition in a conditioned suppression paradigm in humans. Behav Brain Res. 2000;117(1-2):53-60.
34. Salgado JV, Hetem LA, Vidal M, Graeff FG, Danion JM, Sandner G. Reduction of latent inhibition by D-amphetamine in a conditioned suppression paradigm in humans. Behav Brain Res. 2000;117(1-2):61-7.
35. Russig H, Kovacevic A, Murphy CA, Feldon J. Haloperidol and clozapine antagonise amphetamine-induced disruption of latent inhibition of conditioned taste aversion. Psychopharmacology (Berl). 2003;170(3):263-70.
36. Weiner I, Schiller D, Gaisler-Salomon I, Green A, Joel D. A comparison of drug effects in latent inhibition and the forced swim test differentiates between the typical antipsychotic haloperidol, the atypical antipsychotics clozapine and olanzapine, and the antidepressants imipramine and paroxetine. Behav Pharmacol. 2003;14(3):215-22.
37. Weiner I, Feldon J. Phencyclidine does not disrupt latent inhibition in rats: implications for animal models of schizophrenia. Pharmacol Biochem Behav. 1992;42(4):625-31.
38. Lipska BK, Weinberger DR. Delayed effects of neonatal hippocampal damage on haloperidol-induced catalepsy and apomorphine-induced stereotypic behaviors in the rat. Brain Res Dev Brain Res. 1993;75(2):213-22.
39. Lipska BK, Weinberger DR. To model a psychiatric disorder in animals: schizophrenia as a reality test. Neuropsychopharmacology. 2000;23(3):223-39. Review.
40. Castagne V, Rougemont M, Cuenod M, Do KQ. Low brain glutathione and ascorbic acid associated with dopamine uptake inhibition during rat's development long-term cognitive deficits: relevance to schizophrenia. Neurobiol Dis. 2004;15(1):93-105.
41. Jongen-Relo AL, Leng A, Luber M, Pothuizen HH, Weber L, Feldon J. The prenatal methylazoxymethanol acetate treatment: a neurodevelopmental animal model for schizophrenia? Behav Brain Res. 2004;149(2):159-81.
42. Konradi C, Heckers S. Molecular aspects of glutamate dysregulation: implications for schizophrenia and its treatment. Pharmacol Ther. 2003;97(2):153-79.
43. Stevens KE, Johnson RG, Rose GM. Rats reared in social isolation show schizophrenia-like changes in auditory gating. Pharmacol Biochem Behav. 1997;58(4):1031-6.
44. Varty GB, Higgins GA. Examination of drug-induced and isolation-induced disruptions of prepulse inhibition as models to screen antipsychotic drugs. Psychopharmacology (Berl). 1995;122(1):15-26.
45. Leng A, Feldon J, Ferger B. Long-term social isolation and medial prefrontal cortex: dopaminergic and cholinergic neurotransmission. Pharmacol Biochem Behav. 2004;77(2):371-9.
46. Wilkinson LS, Killcross SS, Humby T, Hall FS, Geyer MA, Robbins TW. Social isolation in the rat produces developmentally specific deficits in prepulse inhibition of the acoustic startle response without disrupting latent inhibition. Neuropsychopharmacology. 1994;10(1):61-72.
47. Lehmann J, Pryce CR, Jongen-Relo AL, Stohr T, Pothuizen HH, Feldon J. Comparison of maternal separation and early handling in terms of their neurobehavioral effects in aged rats. Neurobiol Aging. 2002;23(3):457-66.
48. Pryce CR, Feldon J. Long-term neurobehavioural impact of the postnatal environment in rats: manipulations, effects and mediating mechanisms. Neurosci Biobehav Rev. 2003;27(1-2):57-71. Review.
49. Zuckerman L, Rehavi M, Nachman R, Weiner I. Immune activation during pregnancy in rats leads to a postpubertal emergence of disrupted latent inhibition, dopaminergic hyperfunction, and altered limbic morphology in the offspring: a novel neurodevelopmental model of schizophrenia. Neuropsychopharmacology. 2003;28(10):1778-89.
50. Ellenbroek BA, Geyer MA, Cools AR. The behavior of APO-SUS rats in animal models with construct validity for schizophrenia. J Neurosci. 1995;15(11):7604-11.
51. Mohn AR, Gainetdinov RR, Caron MG, Koller BH. Mice with reduced NMDA receptor expression display behaviors related to schizophrenia. Cell. 1999;98(4):427-36.
52. Gogos JA, Santha M, Takacs Z, Beck ZD, Luine V, Lucas LR, Nadler JV, Karayiorgou M. The gene encoding proline dehydrogenase modulates sensorimotor gating in mice. Nature Genet. 1999;21(4):434-9.
53. Goodman AB. Three independent lines of evidence suggest retinoids as causal to schizophrenia. Proc Natl Acad Sci U S A. 1998;95(13):7240-4.
54. Andrieux A, Salin PA, Job D. [A role for microtubules in mental diseases?] Pathol Biol (Paris). 2004;52(2):89-92.
55. Freedman R, Coon H, Myles-Worsley M, Orr-Urtreger A, Olincy A, Davis A, Polymeropoulos M, Holik J, Hopkins J, Hoff M, Rosenthal J, Waldo MC, Reimherr F, Wender P, Yaw J, Young DA, Breese CR, Adams C, Patterson D, Adler LE, Kruglyak L, Leonard S, Byerley W. Linkage of a neurophysiological deficit in schizophrenia to a chromosome 15 locus. Proc Natl Acad Sci U S A. 1997;94(2):587-92.
56. Pinquier C, Heron D, de Carvalho W, Lazar G, Mazet P, Cohen D. [Microdeletion 22q11: apropos of case of schizophrenia in an adolescent]. Encephale. 2001;27(1):45-50.
57. Jentsch JD, Redmond DE Jr, Elsworth JD, Taylor JR, Youngren KD, Roth RH. Enduring cognitive deficits and cortical dopamine dysfunction in monkeys after chronic PCP. Science. 1997;277(5328):953-5.
58. Jentsch JD, Roth RH. The neuropsychopharmacology of phencyclidine: From NMDA receptor hypofunction to the dopaminergic hypothesis of schizophrenia. Neuropsychopharmacology. 1999;20(3):201-25. Review.
59. Suddath RL, Christison GW, Torrey EF, Casanova MF, Weinberger DR. Anatomical abnormalities in the brains of monozygotic twins discordant for schizophrenia. N Engl J Med. 1990;322(12):789-94. Erratum in: N Eng J Med. 1990;322(22):1616.
60. Baddeley AD. Implications of neuropsychological evidence for theories of normal memory. Philos Trans R Soc Lond B Biol Sci. 1982;298(1089):59-72.